Literature DB >> 23496801

Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven by Schistosoma mansoni infection in humans.

Stefan M Geiger1, Anne Jardim-Botelho, Weston Williams, Neal Alexander, David J Diemert, Jeffrey M Bethony.   

Abstract

OBJECTIVES: To evaluate systemic serum cytokine and chemokine markers for inflammation and Th1/Th2 responses in relation to multiple helminth infections, parasite burden and/or nutritional status of individuals.
METHODS: In a longitudinal study, stool samples from 210 individuals from an area highly endemic for Ascaris lumbricoides, Necator americanus and Schistosoma mansoni were examined before and 12 months after clearance of parasites by chemotherapy. On both occasions, the presence of mono- or multiple infections and intensities of infection were compared with nutritional parameters and with serum cytokines or chemokines as markers for inflammatory, regulatory or Th1- or Th2-type immune responses.
RESULTS: Before treatment, we were not able to associate any altered nutritional parameters with increased inflammatory responses, and highest intensities of infection were found in eutrophic participants with multiple infections. In contrast, major changes in serum Th2-type chemokine levels were measured in individuals infected with intestinal helminths and/or S. mansoni, and resulted in significantly higher CCL11 and CCL17 concentrations, both before treatment and after reinfection.
CONCLUSIONS: The driving force for these elevated type 2 serum chemokine concentrations was an S. mansoni infection and faecal egg counts significantly correlated with serum IL-10 concentrations.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23496801     DOI: 10.1111/tmi.12095

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

1.  Schistosoma mansoni PCR+ -infected individuals in the Sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts.

Authors:  K Arndts; T E M Elfaki; N Jelden; M Ritter; A Wiszniewsky; G Katawa; I A Goreish; M E Y A Atti El Mekki; M J Doenhoff; A Hoerauf; L E Layland
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

2.  Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya.

Authors:  Bartholomew N Ondigo; Rachael E Hamilton; Edwin O Magomere; Isaac O Onkanga; Pauline N Mwinzi; Maurice R Odiere; Lisa Ganley-Leal
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

Authors:  Saskia I Johanns; Richard G Gantin; Bawoubadi Wangala; Kossi Komlan; Wemboo A Halatoko; Meba Banla; Potchoziou Karabou; Adrian Jf Luty; Hartwig Schulz-Key; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-05-03

Review 4.  Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship.

Authors:  Mahmoud M Bahgat
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

5.  Systemic Cytokine and Chemokine Profiles in Individuals With Schistosoma mansoni Infection and Low Parasite Burden.

Authors:  Vanessa N Castro; Jailza L Rodrigues; Diogo T Cardoso; Samira D Resende; Fernanda C Magalhães; Dayane C Souza; Maira H Requeijo; Deborah Negrão-Corrêa; Stefan M Geiger
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

6.  Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans.

Authors:  Guilherme Silva Miranda; Samira Diniz Resende; Diogo Tavares Cardoso; Genil Mororó Araújo Camelo; Jeferson Kelvin Alves Oliveira Silva; Vanessa Normandio de Castro; Stefan Michael Geiger; Mariângela Carneiro; Deborah Negrão-Corrêa
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

7.  The "Aging Factor" Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor's Age.

Authors:  Julia Hoefer; Markus Luger; Christian Dal-Pont; Zoran Culig; Harald Schennach; Stefan Jochberger
Journal:  Front Aging Neurosci       Date:  2017-12-01       Impact factor: 5.750

8.  Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up.

Authors:  Beate Grüner; Lynn Peters; Andreas Hillenbrand; Patrick Voßberg; Jonas Schweiker; Elisabeth G Rollmann; Laura H Rodriguez; Jasmin Blumhardt; Sanne Burkert; Peter Kern; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-02-02

9.  Impact of Albendazole on Cytokine and Chemokine Response Profiles in Echinococcus multilocularis-Inoculated Mice.

Authors:  Jing Wu; Hai-Zhang Ma; Shadike Apaer; Nuerzatijiang Anweier; Qi Zeng; Xiafukati Fulati; Tao Li; Jin-Ming Zhao; Hao Wen; Tuerhongjiang Tuxun
Journal:  Biomed Res Int       Date:  2021-05-07       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.